{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:10:13Z","timestamp":1772277013835,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["14858"],"award-info":[{"award-number":["14858"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["15914"],"award-info":[{"award-number":["15914"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["14858.01"],"award-info":[{"award-number":["14858.01"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michael J. Fox Foundation for Parkinson\u2019s Research"},{"name":"Michael J. Fox Foundation for Parkinson\u2019s Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a complex neurodegenerative disorder with diverse clinical manifestations. To better understand this disease, research has been done to categorize, or subtype, patients, using an array of criteria derived from clinical assessments and biospecimen analyses. In this study, using data from the BioFIND cohort, we aimed at identifying subtypes of moderate-to-advanced PD via comprehensively considering motor and non-motor manifestations. A total of 103 patients were included for analysis. Through the use of a patient-wise similarity matrix fusion technique and hierarchical agglomerative clustering analysis, three unique subtypes emerged from the clustering results. Subtype I, comprised of 60 patients (~58.3%), was characterized by mild symptoms, both motor and non-motor. Subtype II, comprised of 20 (~19.4%) patients, was characterized by an intermediate severity, with a high tremor score and mild non-motor symptoms. Subtype III, comprised of 23 (~22.3%) patients, was characterized by more severe motor and non-motor symptoms. These subtypes show statistically significant differences when looking at motor (<jats:italic>on<\/jats:italic> and <jats:italic>off<\/jats:italic> medication) clinical features and non-motor clinical features, while there was no clear difference in demographics, biomarker levels, and genetic risk scores.<\/jats:p>","DOI":"10.1038\/s41531-021-00228-0","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T10:04:13Z","timestamp":1631873053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comprehensive subtyping of Parkinson\u2019s disease patients with similarity fusion: a case study with BioFIND data"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3417-4597","authenticated-orcid":false,"given":"Matthew","family":"Brendel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Henchcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-9461","authenticated-orcid":false,"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"228_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: a review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"key":"228_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0738-x","volume":"17","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad, S.-M. & Postuma, R. B. Subtypes of Parkinson\u2019s disease: what do they tell us about disease progression? Curr. Neurol. Neurosci. Rep. 17, 34 (2017).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"228_CR3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.14336\/AD.2019.0112","volume":"10","author":"YH Elizabeth Qian","year":"2019","unstructured":"Elizabeth Qian, Y. H. Subtyping of Parkinson\u2019s disease\u2014where are we up to? Aging Dis. 10, 1130\u20131139 (2019).","journal-title":"Aging Dis."},{"key":"228_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mds.26913","volume":"32","author":"AJ Espay","year":"2017","unstructured":"Espay, A. J. et al. Biomarker-driven phenotyping in Parkinson\u2019s disease: a translational missing link in disease-modifying clinical trials. Mov. Disord. 32, 319\u2013324 (2017).","journal-title":"Mov. Disord."},{"key":"228_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/mds.26613","volume":"31","author":"UJ Kang","year":"2016","unstructured":"Kang, U. J. et al. The BioFIND study: characteristics of a clinically typical Parkinson\u2019s disease biomarker cohort. Mov. Disord. 31, 924\u2013932 (2016).","journal-title":"Mov. Disord."},{"key":"228_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","volume":"71","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt, M. A. & Jankovic, J. Parkinson disease subtypes. JAMA Neurol. 71, 499\u2013504 (2014).","journal-title":"JAMA Neurol."},{"key":"228_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.parkreldis.2019.06.017","volume":"65","author":"L Luo","year":"2019","unstructured":"Luo, L. et al. Motor phenotype classification in moderate to advanced PD in BioFIND study. Park. Relat. Disord. 65, 178\u2013183 (2019).","journal-title":"Park. Relat. Disord."},{"key":"228_CR8","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins, G. T. et al. How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: Comparison with the unified Parkinson\u2019s disease rating scale. Mov. Disord. 28, 668\u2013670 (2013).","journal-title":"Mov. Disord."},{"key":"228_CR9","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster, K. et al. The REM sleep behavior disorder screening questionnaire\u2014A new diagnostic instrument. Mov. Disord. 22, 2386\u20132393 (2007).","journal-title":"Mov. Disord."},{"key":"228_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.27414","volume":"33","author":"SP Sardi","year":"2018","unstructured":"Sardi, S. P., Cedarbaum, J. M. & Brundin, P. Targeted therapies for Parkinson\u2019s disease: from genetics to the clinic. Mov. Disord. 33, 684\u2013696 (2018).","journal-title":"Mov. Disord."},{"key":"228_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad, S.-M., Zeighami, Y., Dagher, A. & Postuma, R. B. Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140, 1959\u20131976 (2017).","journal-title":"Brain"},{"key":"228_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","volume":"89","author":"M Lawton","year":"2018","unstructured":"Lawton, M. et al. Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression. J. Neurol. Neurosurg. Psychiatry 89, 1279\u20131287 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"228_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37545-z","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Data-driven subtyping of parkinson\u2019s disease using longitudinal clinical records: a cohort study. Sci. Rep. 9, 797 (2019).","journal-title":"Sci. Rep."},{"key":"228_CR14","doi-asserted-by":"publisher","unstructured":"Faghri, F. et al. Predicting onset, progression, and clinical subtypes of Parkinson disease using machine learning. bioRxiv https:\/\/doi.org\/10.1101\/338913 (2018).","DOI":"10.1101\/338913"},{"key":"228_CR15","doi-asserted-by":"crossref","unstructured":"Baytas, I. M. et al. Patient subtyping via time-aware LSTM networks. In Proc. 23rd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 65\u201374 (Association for Computing Machinery, Halifax, NS, Canada, 2017).","DOI":"10.1145\/3097983.3097997"},{"key":"228_CR16","doi-asserted-by":"publisher","first-page":"e0233296","DOI":"10.1371\/journal.pone.0233296","volume":"15","author":"S Krishnagopal","year":"2020","unstructured":"Krishnagopal, S., Coelln, R. V., Shulman, L. M. & Girvan, M. Identifying and predicting Parkinson\u2019s disease subtypes through trajectory clustering via bipartite networks. PLoS ONE 15, e0233296 (2020).","journal-title":"PLoS ONE"},{"key":"228_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2020.11.010","volume":"82","author":"A Inguanzo","year":"2021","unstructured":"Inguanzo, A. et al. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson\u2019s disease. Park. Relat. Disord. 82, 16\u201323 (2021).","journal-title":"Park. Relat. Disord."},{"key":"228_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1109\/TMI.2020.3031478","volume":"40","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Tinaz, S. & Tagare, H. D. Robust Bayesian analysis of early-stage Parkinson\u2019s disease progression using DaTscan images. IEEE Trans. Med. Imaging 40, 549\u2013561 (2021).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"228_CR19","doi-asserted-by":"publisher","first-page":"e1445","DOI":"10.1212\/WNL.0000000000010498","volume":"95","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Association of specific biotypes in patients with Parkinson disease and disease progression. Neurology 95, e1445\u2013e1460 (2020).","journal-title":"Neurology"},{"key":"228_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76200-4","volume":"10","author":"MA Emon","year":"2020","unstructured":"Emon, M. A. et al. Clustering of Alzheimer\u2019s and Parkinson\u2019s disease based on genetic burden of shared molecular mechanisms. Sci. Rep. 10, 19097 (2020).","journal-title":"Sci. Rep."},{"key":"228_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mds.28321","volume":"36","author":"D Belvisi","year":"2021","unstructured":"Belvisi, D. et al. The pathophysiological correlates of Parkinson\u2019s disease clinical subtypes. Mov. Disord. 36, 370\u2013379 (2021).","journal-title":"Mov. Disord."},{"key":"228_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1145\/331499.331504","volume":"31","author":"AK Jain","year":"1999","unstructured":"Jain, A. K., Murty, M. N. & Flynn, P. J. Data clustering: a review. ACM Comput. Surv. 31, 264\u2013323 (1999).","journal-title":"ACM Comput. Surv."},{"key":"228_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nmeth.2810","volume":"11","author":"B Wang","year":"2014","unstructured":"Wang, B. et al. Similarity network fusion for aggregating data types on a genomic scale. Nat. Methods 11, 333\u2013337 (2014).","journal-title":"Nat. Methods"},{"key":"228_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nmeth.4207","volume":"14","author":"B Wang","year":"2017","unstructured":"Wang, B., Zhu, J., Pierson, E., Ramazzotti, D. & Batzoglou, S. Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning. Nat. Methods 14, 414\u2013416 (2017).","journal-title":"Nat. Methods"},{"key":"228_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10115-011-0433-1","volume":"32","author":"F Wang","year":"2012","unstructured":"Wang, F., Li, P., K\u00f6nig, A. C. & Wan, M. Improving clustering by learning a bi-stochastic data similarity matrix. Knowl. Inf. Syst. 32, 351\u2013382 (2012).","journal-title":"Knowl. Inf. Syst."},{"key":"228_CR26","first-page":"441","volume":"6","author":"JN Herb","year":"2016","unstructured":"Herb, J. N. et al. Cortical implications of advancing age and disease duration in Parkinson\u2019s disease patients with postural instability and gait dysfunction. J. Park. Dis. 6, 441\u2013451 (2016).","journal-title":"J. Park. Dis."},{"key":"228_CR27","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","volume":"89","author":"B Mollenhauer","year":"2017","unstructured":"Mollenhauer, B. et al. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology 89, 1959\u20131969 (2017).","journal-title":"Neurology"},{"key":"228_CR28","doi-asserted-by":"publisher","first-page":"e8856","DOI":"10.1371\/journal.pone.0008856","volume":"5","author":"F Simunovic","year":"2010","unstructured":"Simunovic, F., Yi, M., Wang, Y., Stephens, R. & Sonntag, K. C. Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS ONE 5, e8856 (2010).","journal-title":"PLoS ONE"},{"key":"228_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fnins.2019.00255","volume":"13","author":"T-H Lian","year":"2019","unstructured":"Lian, T.-H. et al. Tremor-dominant in Parkinson disease: the relevance to iron metabolism and inflammation. Front. Neurosci. 13, 255 (2019).","journal-title":"Front. Neurosci."},{"key":"228_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-3-29","volume":"3","author":"DA Loeffler","year":"2006","unstructured":"Loeffler, D. A., Camp, D. M. & Conant, S. B. Complement activation in the Parkinson\u2019s disease substantia nigra: an immunocytochemical study. J. Neuroinflammation 3, 29 (2006).","journal-title":"J. Neuroinflammation"},{"key":"228_CR31","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1021\/acs.jproteome.0c01002","volume":"20","author":"S-X Ma","year":"2021","unstructured":"Ma, S.-X. et al. Complement and coagulation cascades are potentially involved in dopaminergic neurodegeneration in \u03b1-synuclein-based mouse models of Parkinson\u2019s disease. J. Proteome Res. 20, 3428\u20133443 (2021).","journal-title":"J. Proteome Res."},{"key":"228_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"228_CR33","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"228_CR34","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1474-4422(15)00178-7","volume":"14","author":"MA Nalls","year":"2015","unstructured":"Nalls, M. A. et al. Diagnosis of Parkinson\u2019s disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol. 14, 1002\u20131009 (2015).","journal-title":"Lancet Neurol."},{"key":"228_CR35","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46, 989\u2013993 (2014).","journal-title":"Nat. Genet."},{"key":"228_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0031-3203(79)90049-9","volume":"11","author":"A Lukasov\u00e1","year":"1979","unstructured":"Lukasov\u00e1, A. Hierarchical agglomerative clustering procedure. Pattern Recognit. 11, 365\u2013381 (1979).","journal-title":"Pattern Recognit."},{"key":"228_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw, P. J. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53\u201365 (1987).","journal-title":"J. Comput. Appl. Math."},{"key":"228_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/nav.3800020109","volume":"2","author":"HW Kuhn","year":"1955","unstructured":"Kuhn, H. W. The Hungarian method for the assignment problem. Nav. Res. Logist. 2, 83\u201397 (1955).","journal-title":"Nav. Res. Logist."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00228-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00228-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00228-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T21:56:43Z","timestamp":1670018203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00228-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1038\/s41531-021-00228-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"23 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}